The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Blood-based biomarker analysis in high PD-L1 expressing NSCLC treated with PD-1/PD-L1 based therapy with or without the addition of platinum-based chemotherapy.
 
Mary J. Fidler
Honoraria - AstraZeneca; Genentech; Merck
Consulting or Advisory Role - Abbvie (I); AstraZeneca; G1 Therapeutics; Genentech (I); Rakuten Medical (Inst)
Speakers' Bureau - Genentech; Merck
Research Funding - AstraZeneca (Inst); Biodesix; CytomX Therapeutics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer/EMD Serono; Rakuten Medical (Inst)
 
Victoria Meucci Villaflor
Consulting or Advisory Role - ARIAD/Takeda; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Genentech/Roche; Novocure
Research Funding - Takeda Science Foundation
Travel, Accommodations, Expenses - ARIAD/Takeda; AstraZeneca; Bristol-Myers Squibb; Novocure
 
Amol Rao
No Relationships to Disclose
 
Balazs Halmos
Consulting or Advisory Role - Apollomics; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; Genentech/Roche; Guardant Health; Lilly; Merck; Novartis; Pfizer; Spectrum Pharmaceuticals; Takeda; Turning Point Therapeutics
Research Funding - Abbvie (Inst); Advaxis (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Elevation Oncology; GlaxoSmithKline (Inst); Guardant Health (Inst); Janssen Oncology (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Erin Marie Bertino
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Pfizer
(OPTIONAL) Uncompensated Relationships - Lilly; Lilly; Merck
 
Raymond U. Osarogiagbon
Stock and Other Ownership Interests - Gilead Sciences; Lilly; Pfizer
Honoraria - Biodes
Consulting or Advisory Role - American Cancer Society; Association of Community Cancer Centers (ACCC); AstraZeneca; Triptych Health Partners
Patents, Royalties, Other Intellectual Property - 2 US and 1 China patents for lymph node specimen collection kit and method of pathologic evaluation.
Other Relationship - Oncobox
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Nexus Pharmaceuticals Inc
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; GlaxoSmithKline; Helsinn Therapeutics; Incyte; Inivata; Inovio Pharmaceuticals; Janssen; Kyowa Hakko Kirin; Loxo; Merck; Novartis; Pfizer; Takeda
Research Funding - Bristol-Myers Squibb